Expert recommendations for the management of refractory gastroesophageal reflux disease in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal “Ad hoc committee”

By afschroeder • June 18, 2026

Hughes M, Cricchio AL, De Santis MC, Alcala-Gonzalez LG, Clarke J, O'Connor A, Bellando-Randone S, Denton CP, Galetti I, Lescoat A, Matucci-Cerinic M, Matucci-Cerinic P, McLaughlin J, Murray C, Pasricha PJ, Volkmann ER, Alunno A, Bandini G, McMahan ZH. Expert recommendations for the management of refractory gastroesophageal reflux disease in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee". J Scleroderma Relat Disord. 2026 Jan;11(1):e000024. doi: 10.1136/jsrd-2026-000024. Epub 2026 Jan 1. PMID: 42311957; PMCID: PMC13271578.

Tags: Gastro-esophageal reflux disease, gerd, management, Publications, Refractory, Rheumatology, Scleroderma, systemic sclerosis

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes

Stirrat T, Wilkey M, Ransibrahmanakul V, Singh L, Allen O, Kanth P, Rangnekar A, Redfield R. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic[...]

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial

Falchi L, Offner F, de Vos S, Brody JD, Morillo D, Linton K, Snauwaert S, Roost Clausen M, Karimi YH, Thieblemont C, Vitolo U, Leslie[...]